IPRP - 13th Meeting - Public Statement Submitted by n.luludi on Wed, 06/19/2024 - 08:22 The thirteenth meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 5th and 6th of
IPRP - 12th Meeting - Public Statement Submitted by n.luludi on Mon, 11/20/2023 - 09:43 The twelfth meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 1st and 2nd of No
Updated IPRP Questions and Answers document on Reliance – now published Submitted by n.luludi on Fri, 06/30/2023 - 08:29 The IPRP is pleased to share an updated Questions and Answers document on key aspects for reliance, that was revised by the IPRP Reliance Discussion G
IPRP Biosimilars Working Group (BWG) Workshop - Updated Submitted by n.luludi on Mon, 06/26/2023 - 14:54 The IPRP Biosimilars Working Group (BWG) is hosting a virtual workshop "Increasing the Efficiency of Biosimilar Development Programs-Reevaluating the
IPRP - 11th Meeting - Public Statement Submitted by n.luludi on Mon, 06/26/2023 - 09:47 The eleventh meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 13th and 14th Ju
CTWG/GTWG - Raw Materials Reflection Paper - now published Submitted by n.luludi on Wed, 03/15/2023 - 13:21 The IPRP Cell Therapy Working Group (CTWG) and Gene Therapy Working Group (GTWG) have developed the Reflection Paper on General Considerations for Raw
IPRP - 10th Meeting - Public Statement Submitted by n.luludi on Thu, 12/01/2022 - 13:55 The tenth meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 16th and 17th&